151 related articles for article (PubMed ID: 32148911)
1. Evaluation of homocystein and asymmetric dimethyl arginine levels in patients with coronary slow flow phenomenon.
Demirci E; Çelik O; Kalçık M; Bekar L; Yetim M; Doğan T
Interv Med Appl Sci; 2019 Jun; 11(2):89-94. PubMed ID: 32148911
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
Yucel H; Ozaydin M; Dogan A; Erdogan D; Turker Y; Ceyhan BM; Sutcu R
Scand J Clin Lab Invest; 2012 Oct; 72(6):495-500. PubMed ID: 22950626
[TBL] [Abstract][Full Text] [Related]
4. Relationship between L-arginine/asymmetric dimethylarginine, homocysteine, folic acid, vitamin B levels, and coronary artery ectasia.
Koc F; Ardic I; Erdem S; Kalay N; Ozbek K; Yarlioglues M; Ceyhan K; Celik A; Kadi H; Taner A; Sahin S; Onalan O; Kaya MG
Coron Artery Dis; 2010 Dec; 21(8):445-9. PubMed ID: 20861735
[TBL] [Abstract][Full Text] [Related]
5. Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X.
Okyay K; Cengel A; Sahinarslan A; Tavil Y; Turkoglu S; Biberoglu G; Hasanoglu A
Coron Artery Dis; 2007 Nov; 18(7):539-44. PubMed ID: 17925607
[TBL] [Abstract][Full Text] [Related]
6. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow.
Tanriverdi H; Evrengul H; Enli Y; Kuru O; Seleci D; Tanriverdi S; Tuzun N; Kaftan HA; Karabulut N
Cardiology; 2007; 107(4):313-20. PubMed ID: 17264512
[TBL] [Abstract][Full Text] [Related]
7. Carotid intima-media thickness in coronary slow flow: relationship with plasma homocysteine levels.
Tanriverdi H; Evrengul H; Tanriverdi S; Kuru O; Seleci D; Enli Y; Kaftan A; Kilic M
Coron Artery Dis; 2006 May; 17(4):331-7. PubMed ID: 16707955
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ghrelin levels and endothelial functions in patients with coronary slow flow phenomenon.
Çelik O; Demirci E; Aydın M; Karabag T; Kalçık M
Interv Med Appl Sci; 2017 Sep; 9(3):154-159. PubMed ID: 29201440
[TBL] [Abstract][Full Text] [Related]
9. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon.
Evrengul H; Tanriverdi H; Enli Y; Kuru O; Seleci D; Bastemir M; Kilic A; Kaftan A; Kilic M
Cardiology; 2007; 108(3):186-92. PubMed ID: 17085937
[TBL] [Abstract][Full Text] [Related]
10. The effects of endothelial dysfunction and inflammation on slow coronary flow.
Arı H; Arı S; Erdoğan E; Tiryakioğlu O; Huysal K; Koca V; Bozat T
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Correlation between Serum Concentrations of Asymmetric Dimethylarginine and Corrected TIMI Frame Count in Patients with Slow Coronary Flow.
Naserifar M; Ataei M; Behzadian N; Mohammadpour AH; Dastani M; Sahebkar A; Hosseinjani H
Int J Vasc Med; 2020; 2020():4592190. PubMed ID: 33014469
[TBL] [Abstract][Full Text] [Related]
12. Elevated level of plasma homocysteine in patients with slow coronary flow.
Riza Erbay A; Turhan H; Yasar AS; Ayaz S; Sahin O; Senen K; Sasmaz H; Yetkin E
Int J Cardiol; 2005 Jul; 102(3):419-23. PubMed ID: 16004886
[TBL] [Abstract][Full Text] [Related]
13. Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine-NO pathway metabolite levels in patients with psoriasis.
Bilgiç Ö; Altınyazar HC; Baran H; Ünlü A
Arch Dermatol Res; 2015 Jul; 307(5):439-44. PubMed ID: 25708188
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of plasma asymmetric dimethylarginine, homocysteine, and high-sensitive CRP levels in occult coronary artery disease: A multidetector-row computed tomography study.
Gürel E; Tigen K; Karaahmet T; Geçmen Ç; Mutlu B; Başaran Y
Herz; 2015 May; 40(3):495-501. PubMed ID: 24357092
[TBL] [Abstract][Full Text] [Related]
16. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection.
Evrengul H; Tanriverdi H; Kuru O; Enli Y; Yuksel D; Kilic A; Kaftan A; Kirac S; Kilic M
Helicobacter; 2007 Aug; 12(4):298-305. PubMed ID: 17669101
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Plasma Thrombomodulin in Patients with Coronary Slow Flow.
Wang Y; Jia PY; Chen BJ; Chen Y; Yu H; Yu Y; Yang HM; Jia DL; Ma CY
Cardiology; 2017; 138(3):141-146. PubMed ID: 28651248
[TBL] [Abstract][Full Text] [Related]
18. Ratio Of Serum Asymmetric Dimethyl Arginine (ADMA)/ Nitric Oxide in Coronary Artery Disease patients.
Shivkar RR; Abhang SA
J Clin Diagn Res; 2014 Aug; 8(8):CC04-6. PubMed ID: 25302189
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function.
Wilcken DE; Wang J; Sim AS; Green K; Wilcken B
J Inherit Metab Dis; 2006 Feb; 29(1):30-7. PubMed ID: 16601865
[TBL] [Abstract][Full Text] [Related]
20. [Asymmetric dimethyl arginine (ADMA): a novel cardiovascular risk factor?].
Stühlinger M
Wien Med Wochenschr; 2007 Feb; 157(3-4):57-60. PubMed ID: 17340060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
